Physician-scientist Conan Kinsey gives three reasons why pancreatic cancer has one of the lowest survival rates for any kind of cancer and explains how federally and donor-funded research provides hope.
If pancreatic cancer runs in your family, learn how genetic testing can guide treatment, screenings, and risk reduction from Huntsman Cancer Institute genetic counselor Sam Beck, MS, CGC.
After being diagnosed with pancreatic cancer, Noelle Gatlin found strength in her family, work, and music. Through treatment challenges, she remained resilient, embracing life with renewed purpose and joy.
Ricky Harbison’s rare cancer diagnosis led him to Huntsman Cancer Institute and Helosia Soares, MD. Under her care and expertise, Ricky continues to enjoy the things he loves most.
Kim Kaphingst, ScD; June Round, PhD; and Neli Ulrich, PhD, MS, have been recognized by the University of Utah for their exemplary work in cancer research.
Marshall Baker, MD, MBA, surgical director of liver oncology research, describes complex foregut oncology, the liver transplant oncology program, improvements in cancer care, and what makes Huntsman Cancer Institute unique.
Cancer has had a profound impact on Sara Bryant-Hart’s family. Genetic counselors at Huntsman Cancer Institute wondered why and then found the reason: Lynch syndrome.
Jerry Simonson was diagnosed with pancreatic cancer in 2017. Now, the 76-year-old is thriving thanks to a cutting-edge clinical trial at Huntsman Cancer Institute.
Read how scientists reduce infection risk after pancreatic surgery, discover the best cost-effective treatment for prostate cancer, learn which lung cancer patients have the most emergency department visits, and more.
Read how researchers discovered genetic markers that hinder pancreatic cancer treatment and mutations that increase sarcoma risk. Then learn how artificial intelligence is helping predict prostate cancer outcomes and see...
Professor Martin McMahon has dedicated his career to making an impact on cancer through research and mentoring trainees in his lab. The native Scot recently returned to his homeland to...
Huntsman Cancer Institute investigators Doug Grossman, MD, PhD, Conan Kinsey, MD, PhD, and Keren Hilgendorf, PhD, received grants from the V Foundation to fund cancer research. The grants total $1,000,000...
The Pancreatic Cancer Action Network has announced the latest updates to its innovative adaptive clinical trial, Precision PromiseSM, including the addition of an investigational treatment from global healthcare company, Novartis...
Collaboration is at the heart of Huntsman Cancer Institute’s culture. Fueled by dedication, lab scientists make progress each day toward understanding cancer from its beginnings. Recently, a pair of studies...
Gastrointestinal oncologist Ignacio Garrido-Laguna, MD, PhD, talks about his medical training in Spain, including how it is similar to Utah, and what he hopes for the future of pancreas cancer.
